Inactivation of p16INK4a expression in malignant mesothelioma by methylation

Lung Cancer

Volumn 38, Issue 2, 2002, Pages 131-136

  Wong, Long ^a,b   Zhou, Joan ^a,b   Anderson, Daniel ^a   Kratzke, Robert A ^a,b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

cdk; Cell cycle; Epigenetic

Indexed keywords

ARTICLE; CELL CYCLE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DNA METHYLATION; EXON; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; MESOTHELIOMA; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; GENETICS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION;

PROTEIN P16INK4A;

CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESOTHELIOMA; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0036837992     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00178-2     Document Type: Article

References (35)

1. Benign and malignant mesothelioma
2. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma
3. Cancer cell cycles
4. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
5. Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells
6. Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus
7. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression
8. Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma
9. Analysis of the p16 gene (CDKN2) as a candidate for the chromsome 9p melanoma susceptibility locus
10. A cell cycle regulator potentially involved in genesis of many tumor types
11. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
12. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′deoxycytidine
13. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer
14. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
15. DNA methylation and expression of p16(INK4A) gene in pulmonary adenocarcinoma and anthracosis in background lung
16. Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers
17. Frequent aberrant methylation of p16INK4a in primary rat lung tumors
18. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines
19. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer
20. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
21. Novel therapeutic agents for the treatment of myelodysplastic syndromes
22. P15INK4b gene methylation and myelodysplastic syndromes
23. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes
24. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes
25. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression
26. Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B
27. Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
28. Characteristics of nine newly derived mesothelioma cell lines
29. In vitro and in vivo studies of mesothelioma
30. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands
31. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma
32. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
33. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB